Comparative Analysis of Species-Specific Ligand Recognition in Toll-Like Receptor 8 Signaling: A Hypothesis
暂无分享,去创建一个
Sangdun Choi | Rajiv Gandhi Govindaraj | Balachandran Manavalan | Shaherin Basith | Balachandran Manavalan | Sangdun Choi | S. Basith | R. Govindaraj | Shaherin Basith
[1] S. Paik,et al. Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide , 2007, Cell.
[2] Sangdun Choi,et al. Toll-like receptor modulators: a patent review (2006 – 2010) , 2011, Expert opinion on therapeutic patents.
[3] A. Ishii,et al. Combinational recognition of bacterial lipoproteins and peptidoglycan by chicken Toll-like receptor 2 subfamily. , 2008, Developmental and comparative immunology.
[4] Shaila C. Rössle,et al. Homology modeling of human Toll‐like receptors TLR7, 8, and 9 ligand‐binding domains , 2009, Protein science : a publication of the Protein Society.
[5] Adriaan P IJzerman,et al. Selective allosteric enhancement of agonist binding and function at human A3 adenosine receptors by a series of imidazoquinoline derivatives. , 2002, Molecular pharmacology.
[6] Hayyoung Lee,et al. Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran , 2007, Cell.
[7] L. Babiuk,et al. Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod. , 2008, Molecular immunology.
[8] Zsolt Bikádi,et al. Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock , 2009, J. Cheminformatics.
[9] D. Werling,et al. Host species-specific usage of the TLR4-LPS receptor complex , 2008, Innate immunity.
[10] B. Monks,et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9 , 2007, Nature Immunology.
[11] Gert Vriend,et al. Making optimal use of empirical energy functions: Force‐field parameterization in crystal space , 2004, Proteins.
[12] T. Giese,et al. Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.
[13] Y. Kuroki,et al. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors , 2007, BMC Genomics.
[14] François Stricher,et al. The FoldX web server: an online force field , 2005, Nucleic Acids Res..
[15] Marion Jurk,et al. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T‐rich phosphorothiate oligodeoxynucleotides , 2006, European journal of immunology.
[16] Jongdae Lee,et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] Sangdun Choi,et al. Molecular Modeling-Based Evaluation of hTLR10 and Identification of Potential Ligands in Toll-Like Receptor Signaling , 2010, PloS one.
[18] Shaila C. Rössle,et al. TollML: a database of toll-like receptor structural motifs , 2010, Journal of molecular modeling.
[19] Sandor Vajda,et al. ClusPro: a fully automated algorithm for protein-protein docking , 2004, Nucleic Acids Res..
[20] P. Nordlund,et al. The Crystal Structure of the Human Toll-like Receptor 10 Cytoplasmic Domain Reveals a Putative Signaling Dimer* , 2008, Journal of Biological Chemistry.
[21] L. Babiuk,et al. Characterization of bovine Toll-like receptor 8: ligand specificity, signaling essential sites and dimerization. , 2009, Molecular immunology.
[22] O. Jann,et al. Variation matters: TLR structure and species-specific pathogen recognition. , 2009, Trends in immunology.
[23] D. Eisenberg,et al. VERIFY3D: assessment of protein models with three-dimensional profiles. , 1997, Methods in enzymology.
[24] H. Wagner,et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.
[25] J. Metzger,et al. Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner , 2004, European journal of immunology.
[26] M. Tomai,et al. Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463. , 1997, Cytokine.
[27] John P. Vasilakos,et al. Cutting Edge: Activation of Murine TLR8 by a Combination of Imidazoquinoline Immune Response Modifiers and PolyT Oligodeoxynucleotides , 2006, The Journal of Immunology.
[28] Junmei Wang,et al. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000, J. Comput. Chem..
[29] S. Akira,et al. Pathogen recognition by innate immunity and its signaling , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[30] S. Akira,et al. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.
[31] S. Akira,et al. The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily , 2003, European journal of immunology.
[32] David S. Goodsell,et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..
[33] Sankar Ghosh,et al. Recognition and signaling by toll-like receptors. , 2006, Annual review of cell and developmental biology.
[34] T. Yeates,et al. Verification of protein structures: Patterns of nonbonded atomic interactions , 1993, Protein science : a publication of the Protein Society.
[35] András Fiser,et al. ModLoop: automated modeling of loops in protein structures , 2003, Bioinform..
[36] R. Miller,et al. The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells. , 2000, Clinical immunology.
[37] S. Akira,et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.
[38] L. Federici,et al. The crystal structure of polygalacturonase-inhibiting protein (PGIP), a leucine-rich repeat protein involved in plant defense , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. V. van Putten,et al. The Central Leucine-Rich Repeat Region of Chicken TLR16 Dictates Unique Ligand Specificity and Species-Specific Interaction with TLR21 , 2007, The Journal of Immunology.
[40] Andrey Tovchigrechko,et al. GRAMM-X public web server for protein–protein docking , 2006, Nucleic Acids Res..
[41] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[42] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[43] G. Barton. Viral recognition by Toll-like receptors. , 2007, Seminars in immunology.
[44] D. Davies,et al. Leucine-rich repeats and pathogen recognition in Toll-like receptors. , 2003, Trends in immunology.
[45] D. Davies,et al. The molecular structure of the TLR3 extracellular domain , 2006, Journal of endotoxin research.
[46] B. Monks,et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. , 2000, The Journal of clinical investigation.
[47] D. Bernstein,et al. Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment. , 2001, The Journal of infectious diseases.
[48] S. Paik,et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. , 2009, Immunity.
[49] T L Blundell,et al. FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. , 2001, Journal of molecular biology.
[50] A. Aderem,et al. A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin , 2007, The Journal of experimental medicine.
[51] D. Davies,et al. Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA , 2008, Science.
[52] B. Kobe,et al. The leucine-rich repeat as a protein recognition motif. , 2001, Current opinion in structural biology.
[53] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[54] C. Bryant,et al. The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist , 2007, Journal of endotoxin research.
[55] I. Wilson,et al. Crystal Structure of Human Toll-Like Receptor 3 (TLR3) Ectodomain , 2005, Science.
[56] R. Xiang,et al. A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition. , 2010, Molecular immunology.
[57] R. Miller,et al. Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463. , 1998, The Journal of investigative dermatology.
[58] Hayyoung Lee,et al. The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.
[59] B. Beutler. TLRs and innate immunity. , 2009, Blood.
[60] Manfred J. Sippl,et al. Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..
[61] Sandor Vajda,et al. ClusPro: an automated docking and discrimination method for the prediction of protein complexes , 2004, Bioinform..
[62] Sangdun Choi,et al. In Silico Approach to Inhibition of Signaling Pathways of Toll-Like Receptors 2 and 4 by ST2L , 2011, PloS one.
[63] N. Gay,et al. Conserved Features in the Extracellular Domain of Human Toll-like Receptor 8 Are Essential for pH-dependent Signaling* , 2006, Journal of Biological Chemistry.
[64] J. Thornton,et al. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.
[65] A. Kaur,et al. The evolution of vertebrate Toll-like receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.